NBIO
Price:
$0.05505
Market Cap:
$9.48M
Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. In addition, the company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. Nascent Biotech, Inc. is based in Vero Beach, Florida.[Read more]
Industry
Biotechnology
IPO Date
2009-12-03
Stock Exchange
PNK
Ticker
NBIO
According to Nascent Biotech, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 9.49M. This represents a change of -58.75% compared to the average of 23.01M of the last 4 quarters.
The mean historical Enterprise Value of Nascent Biotech, Inc. over the last ten years is 9.63M. The current 9.49M Enterprise Value has changed 9.76% with respect to the historical average. Over the past ten years (40 quarters), NBIO's Enterprise Value was at its highest in in the September 2022 quarter at 35.66M. The Enterprise Value was at its lowest in in the December 2015 quarter at 3.05M.
Average
9.63M
Median
7.08M
Minimum
4.65M
Maximum
27.79M
Discovering the peaks and valleys of Nascent Biotech, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 20.35%
Maximum Annual Enterprise Value = 27.79M
Minimum Annual Increase = -52.17%
Minimum Annual Enterprise Value = 4.65M
Year | Enterprise Value | Change |
---|---|---|
2024 | 27.79M | 303.45% |
2023 | 6.89M | 13.89% |
2022 | 6.05M | 30.17% |
2021 | 4.65M | -50.33% |
2020 | 9.35M | 77.99% |
2019 | 5.25M | -17.30% |
2018 | 6.35M | -12.74% |
2017 | 7.28M | -0.74% |
2016 | 7.34M | -52.17% |
2015 | 15.34M | 20.35% |
The current Enterprise Value of Nascent Biotech, Inc. (NBIO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
13.57M
5-year avg
10.94M
10-year avg
9.63M
Nascent Biotech, Inc.’s Enterprise Value is greater than ProtoKinetix, Incorporated (3.94M), greater than RespireRx Pharmaceuticals Inc. (2.94M), greater than Silo Pharma, Inc. (247.23K), greater than VG Life Sciences Inc. (4.22M), less than Mymetics Corporation (0), less than Neutra Corp. (75.33M), greater than Protagenic Therapeutics, Inc. (345.61K), less than Sino Biopharmaceutical Limited (0), greater than ZIVO Bioscience, Inc. (1.79M), less than Cyteir Therapeutics, Inc. (9.26B), less than Eledon Pharmaceuticals, Inc. (69.40M), greater than Innovation Pharmaceuticals Inc. (-20511738.00), less than Allena Pharmaceuticals, Inc. (254.81M), less than YS Biopharma Co., Ltd. (0), greater than null (-368993.00), greater than null (-29461000.00), less than null (1.70B),
Company | Enterprise Value | Market cap |
---|---|---|
3.94M | $3.94M | |
2.94M | $730.84K | |
247.23K | $4.75M | |
4.22M | $2.11M | |
0 | $303.76K | |
75.33M | $291.79K | |
345.61K | $2.71M | |
0 | $8.30B | |
1.79M | $68.83M | |
9.26B | $108.71M | |
69.40M | $280.20M | |
-20511738.00 | $257.01K | |
254.81M | $122.00 | |
0 | $192.09M | |
-368993.00 | $0 | |
-29461000.00 | $0 | |
1.70B | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nascent Biotech, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nascent Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Nascent Biotech, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Nascent Biotech, Inc. (NBIO)?
What is the 3-year average Enterprise Value for Nascent Biotech, Inc. (NBIO)?
What is the 5-year average Enterprise Value for Nascent Biotech, Inc. (NBIO)?
How does the current Enterprise Value for Nascent Biotech, Inc. (NBIO) compare to its historical average?